Medications for Osteomalacia
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Osteomalacia.
Found 1 Approved Drug for Osteomalacia
Crysvita
Generic Name
Burosumab
Crysvita
Generic Name
Burosumab
Form: Injection
Method of administration: Subcutaneous
FDA approval date: April 18, 2018
CRYSVITA is a fibroblast growth factor 23 (FGF23) blocking antibody indicated for: The treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances